Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccinationYu Sawada, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Human Vaccines & Immunotherapeutics|2013Cited by 30
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsChigusa Morizane, Tomohiro Yamaguchi, Masafumi Ikeda et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 8